| The structure of the ferromagnetic phase of carbon AA Ovchinnikov, IL Shamovsky Journal of Molecular Structure: THEOCHEM 251, 133-140, 1991 | 103 | 1991 |
| Reciprocal modulation of TrkA and p75NTR affinity states is mediated by direct receptor interactions GM Ross, IL Shamovsky, G Lawrance, M Solc, SM Dostaler, DF Weaver, ... European Journal of Neuroscience 10 (3), 890-898, 1998 | 96 | 1998 |
| Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins GM Ross, IL Shamovsky, G Lawrance, M Solc, SM Dostaler, SL Jimmo, ... Nature medicine 3 (8), 872-878, 1997 | 93 | 1997 |
| Explanation for main features of structure–genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2 I Shamovsky, L Ripa, L Borjesson, C Mee, B Nordén, P Hansen, ... Journal of the American Chemical Society 133 (40), 16168-16185, 2011 | 77 | 2011 |
| The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modeling study IL Shamovsky, GM Ross, RJ Riopelle, DF WEAVER Protein science 8 (11), 2223-2233, 1999 | 73 | 1999 |
| Theoretical studies on the origin of β-sheet twisting IL Shamovsky, GM Ross, RJ Riopelle The Journal of Physical Chemistry B 104 (47), 11296-11307, 2000 | 68 | 2000 |
| Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity RJ Riopelle, GM Ross, MI Dory, DF Weaver, IL Shamovsky US Patent 6,291,247, 2001 | 64 | 2001 |
| Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4, 9-dihydro-4-methyl-9-oxo-pyrazolo [5, 1-b] quinazoline-2-carboxylic acid … A Colquhoun, GM Lawrance, IL Shamovsky, RJ Riopelle, GM Ross Journal of Pharmacology and Experimental Therapeutics 310 (2), 505-511, 2004 | 63 | 2004 |
| Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships I Shamovsky, S Connolly, L David, S Ivanova, B Nordén, B Springthorpe, ... Journal of medicinal chemistry 51 (5), 1162-1178, 2008 | 61 | 2008 |
| Zinc inhibits p75NTR-mediated apoptosis in chick neural retina C Allington, IL Shamovsky, GM Ross, RJ Riopelle Cell Death & Differentiation 8 (5), 451-456, 2001 | 50 | 2001 |
| Ab initio prediction of the structure and stabilities of the hypermagnesium oxide molecules: Mg2O, Mg3O, and Mg4O AI Boldyrev, IL Shamovskii, PR Schleyer Journal of the American Chemical Society 114 (16), 6469-6475, 1992 | 38 | 1992 |
| Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites I Shamovsky, C de Graaf, L Alderin, M Bengtsson, H Bladh, L Börjesson, ... Journal of medicinal chemistry 52 (23), 7706-7723, 2009 | 37 | 2009 |
| Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA I Shamovsky, L Ripa, N Blomberg, LA Eriksson, P Hansen, C Mee, ... Chemical Research in Toxicology 25 (10), 2236-2252, 2012 | 36 | 2012 |
| The binding of zinc and copper ions to nerve growth factor is differentially affected by pH: implications for cerebral acidosis GM Ross, IL Shamovsky, SB Woo, JI Post, PN Vrkljan, G Lawrance, ... Journal of neurochemistry 78 (3), 515-523, 2001 | 35 | 2001 |
| Novel Diazaspiroalkanes and Their Use for Treatment of Ccr8 Mediated Diseases H Bladh, S Connolly, H Dyke, A Lisius, S Price, I Shamovsky, ... US Patent App. 10/575,525, 2007 | 32 | 2007 |
| Ab initio studies on the mechanism of tyrosine coupling IL Shamovsky, RJ Riopelle, GM Ross The Journal of Physical Chemistry A 105 (6), 1061-1070, 2001 | 32 | 2001 |
| Discovery and early clinical development of an inhibitor of 5-lipoxygenase activating protein (AZD5718) for treatment of coronary artery disease D Pettersen, J Broddefalk, H Emtenäs, MA Hayes, M Lemurell, ... Journal of Medicinal Chemistry 62 (9), 4312-4324, 2019 | 31 | 2019 |
| Method of inhibiting neurotrophin-receptor binding GM Ross, IL Shamovsky, S Marone, DF Weaver, RJ Riopelle US Patent 6,492,380, 2002 | 31 | 2002 |
| Molecular modelling of neurotrophin-receptor binding IL Shamovsky, GM Ross, RJ Riopelle, DF Weaver US Patent 6,029,114, 2000 | 30 | 2000 |
| Theoretical and biochemical studies on the selectivity of nerve growth factor for transition metal cations IL Shamovsky, GM Ross, RJ Riopelle, DF Weaver Journal of the American Chemical Society 121 (42), 9797-9806, 1999 | 24 | 1999 |
Peter SjöDrugs for Neglected Disease initiative在 dndi.org 的电子邮件经过验证
